249 related articles for article (PubMed ID: 29976499)
41. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas.
Richard P; Phillips M; Smith W; Davidson D; Kim E; Kane G
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):999-1008. PubMed ID: 27130792
[TBL] [Abstract][Full Text] [Related]
42. Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
Tatebe H; Doi H; Ishikawa K; Kawakami H; Yokokawa M; Nakamatsu K; Kanamori S; Shibata T; Kitano M; Nishimura Y
Anticancer Res; 2018 Feb; 38(2):979-986. PubMed ID: 29374730
[TBL] [Abstract][Full Text] [Related]
43. Nodal response after 46 Gy of intensity-modulated radiotherapy is associated with human papillomavirus-related oropharyngeal carcinoma.
Dronkers EAC; Koljenovic S; Verduijn GM; Baatenburg de Jong RJ; Hardillo JAU
Laryngoscope; 2018 Oct; 128(10):2333-2340. PubMed ID: 29521420
[TBL] [Abstract][Full Text] [Related]
44. Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer.
Chen AM; Li J; Beckett LA; Zhara T; Farwell G; Lau DH; Gandour-Edwards R; Vaughan AT; Purdy JA
Laryngoscope; 2013 Jan; 123(1):152-7. PubMed ID: 23008061
[TBL] [Abstract][Full Text] [Related]
45. Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.
Ojerholm E; Kirk ML; Thompson RF; Zhai H; Metz JM; Both S; Ben-Josef E; Plastaras JP
Acta Oncol; 2015; 54(8):1209-17. PubMed ID: 25734796
[TBL] [Abstract][Full Text] [Related]
46. Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer.
Parthan A; Pruttivarasin N; Davies D; Taylor DC; Pawar V; Bijlani A; Lich KH; Chen RC
Front Oncol; 2012; 2():81. PubMed ID: 22934286
[TBL] [Abstract][Full Text] [Related]
47. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
[TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
Mori T; Crandall CJ; Ganz DA
Osteoporos Int; 2017 Feb; 28(2):585-595. PubMed ID: 27726000
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
[TBL] [Abstract][Full Text] [Related]
51. Establishing Cost-Effective Allocation of Proton Therapy for Breast Irradiation.
Mailhot Vega RB; Ishaq O; Raldow A; Perez CA; Jimenez R; Scherrer-Crosbie M; Bussiere M; Taghian A; Sher DJ; MacDonald SM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):11-18. PubMed ID: 27084617
[TBL] [Abstract][Full Text] [Related]
52. Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2): positive advanced breast cancer.
Le QA; Bae YH; Kang JH
Breast Cancer Res Treat; 2016 Oct; 159(3):565-73. PubMed ID: 27572338
[TBL] [Abstract][Full Text] [Related]
53. Finding Value for Protons: The Case of Prostate Cancer?
Ojerholm E; Bekelman JE
Semin Radiat Oncol; 2018 Apr; 28(2):131-137. PubMed ID: 29735189
[TBL] [Abstract][Full Text] [Related]
54. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness analysis of radiotherapy techniques for whole breast irradiation.
Xie Y; Guo B; Zhang R
PLoS One; 2021; 16(3):e0248220. PubMed ID: 33684139
[TBL] [Abstract][Full Text] [Related]
56. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.
Lin SH; Hobbs BP; Verma V; Tidwell RS; Smith GL; Lei X; Corsini EM; Mok I; Wei X; Yao L; Wang X; Komaki RU; Chang JY; Chun SG; Jeter MD; Swisher SG; Ajani JA; Blum-Murphy M; Vaporciyan AA; Mehran RJ; Koong AC; Gandhi SJ; Hofstetter WL; Hong TS; Delaney TF; Liao Z; Mohan R
J Clin Oncol; 2020 May; 38(14):1569-1579. PubMed ID: 32160096
[TBL] [Abstract][Full Text] [Related]
57. Magnitude of benefit for adjuvant radiotherapy following minimally invasive surgery in intermediate to high risk HPV-positive oropharyngeal squamous cell carcinoma.
Pasalic D; Funk RK; García JJ; Price DL; Price KA; Harmsen WS; Patel SH; Young GD; Foote RL; Moore EJ; Ma DJ
Oral Oncol; 2018 Jul; 82():181-186. PubMed ID: 29909895
[TBL] [Abstract][Full Text] [Related]
58. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.
Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599
[TBL] [Abstract][Full Text] [Related]
59. Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older.
Ward MC; Vicini F; Al-Hilli Z; Chadha M; Pierce L; Recht A; Hayman J; Thaker N; Khan AJ; Keisch M; Shah C
Breast Cancer Res Treat; 2020 Jul; 182(2):355-365. PubMed ID: 32468336
[TBL] [Abstract][Full Text] [Related]
60. Advances in radiation oncology for the management of oropharyngeal tumors.
Gunn GB; Frank SJ
Otolaryngol Clin North Am; 2013 Aug; 46(4):629-43. PubMed ID: 23910474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
